儿科放射学会会员中钆基对比剂使用情况调查:质量与安全委员会报告
儿科放射学会质量与安全委员会向会员发放15题在线调查,评估钆基对比剂使用现状。共163份回复(占邀请的11.1%),多数来自美国学术机构。94%报告MR检查始终或通常由儿科放射医师制定方案;常用对比剂包括Eovist(60.7%)、Ablavar(45.4%)等。部分适应症使用与ACR适宜性标准一致,但生长激素缺乏和疑似血管环等存在潜在过度使用。
要点
- 94%的受访者报告MR检查始终或通常由儿科放射医师制定方案。
- 最常用钆基对比剂为Eovist(60.7%)、Ablavar(45.4%)、Gadovist(38.7%)、Magnevist(34.4%)和Dotarem(32.5%)。
- 癫痫、头痛和骨髓炎等适应症的对比剂使用与ACR适宜性标准一致,而生长激素缺乏和疑似血管环存在潜在过度使用。
核心结论
- 调查结果显示钆基对比剂在儿童中使用较为审慎,但仍有改进使用以降低未来潜在不良反应的机会。
研究设计与样本
- 儿科放射学会质量与安全委员会发起的15题在线调查,发放给学会会员,共纳入163份回复(占邀请的11.1%),多数来自美国学术机构。
诊断标准与关键数值
- 94%的受访者报告MR检查始终或通常由儿科放射医师制定方案。
- 最常用钆基对比剂为Eovist(60.7%)、Ablavar(45.4%)、Gadovist(38.7%)、Magnevist(34.4%)和Dotarem(32.5%)。
- 癫痫、头痛和骨髓炎等适应症的对比剂使用与ACR适宜性标准一致;生长激素缺乏和疑似血管环相比ACR推荐存在潜在过度使用。
临床应用与阅片要点
- 原文结论指出钆基对比剂在儿童中使用较为审慎,但仍有改进使用以降低未来潜在不良反应的机会。
局限性
- 调查回复率为11.1%(163份回复/邀请),原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Gadolinium-based contrast agents (GBCAs) have been used for magnetic resonance (MR) imaging over the last three decades. Recent reports demonstrated gadolinium retention in patients' brains following intravenous administration. Since gadolinium is a highly toxic heavy metal, there is a potential for adverse effects from prolonged retention or deposition, particularly in children. For this reason, the Society (SPR) for Pediatric Radiology Quality and Safety committee conducted a survey to evaluate the current status of GBCAs usage among pediatric radiologists.
OBJECTIVE: To assess the usage of GBCAs among SPR members.
MATERIALS AND METHODS: An online 15-question survey was distributed to SPR members. Survey questions pertained to the type of GBCAs used, protocoling workflow, requirement of renal function or pregnancy tests, and various clinical indications for contrast-enhanced MRI examinations.
RESULTS: A total of 163 survey responses were compiled (11.1% of survey invitations), the majority of these from academic institutions in the United States. Ninety-four percent reported that MR studies are always or usually protocoled by pediatric radiologists. The most common GBCA utilized by survey respondents were Eovist (60.7%), Ablavar (45.4%), Gadovist (38.7%), Magnevist (34.4%) and Dotarem (32.5%). For several clinical indications, survey responses regarding GBCA administration were concordant with American College of Radiology (ACR) Appropriateness Criteria, including seizures, headache and osteomyelitis. For other indications, including growth hormone deficiency and suspected vascular ring, survey responses revealed potential overutilization of GBCAs when compared to ACR recommendations.
CONCLUSION: Survey results demonstrate that GBCAs are administered judiciously in children, yet there is an opportunity to improve their utilization with the goal of reducing potential future adverse effects.
引用
- Blumfield E, Moore MM, Drake MK, et al. Survey of gadolinium-based contrast agent utilization among the members of the Society for Pediatric Radiology: a Quality and Safety Committee report. Pediatr Radiol. 2017. PMID: 28283728. doi:10.1007/s00247-017-3807-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。